ClinicalTrials.Veeva

Menu

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Stanford University logo

Stanford University

Status

Terminated

Conditions

Blood Stem Cell Transplant Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01135355
14862 (Other Identifier)
SU-09222008-1301
PEDSHSCT0002
PEDSBMT199

Details and patient eligibility

About

The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Enrollment

26 patients

Sex

All

Ages

Under 21 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.

  • Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50
  • Ability to understand and the willingness to sign a written informed consent document.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems